HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The addition of aminoacids and phosphate to hemodiafiltration solutions in newborns with hyperammonemic coma.

Abstract
A child with carbamyl-phosphate-synthetase defect who died after prolonged continuous hemodiafiltration in deep coma proved to have high aminoacid losses despite aminoacid infusion. We think that this results from high small-solute clearance during hemodialysis. In order to prevent these inevitable catabolic side-effects we decided to add aminoacids to the dialysate and substitution fluid in these children with metabolic diseases. Additionally we propose to add phosphate in order to avoid depletion. The aim is to achieve anabolic or at least non-catabolic hemodiafiltration.
AuthorsS Fründ, E Kuwertz-Bröking, H G Koch, M Bulla, E Harms
JournalClinical nephrology (Clin Nephrol) Vol. 46 Issue 1 Pg. 64-6 (Jul 1996) ISSN: 0301-0430 [Print] Germany
PMID8832155 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Amino Acids
  • Dialysis Solutions
  • Phosphates
  • Ammonia
  • Carbamoyl-Phosphate Synthase (Ammonia)
Topics
  • Amino Acids (therapeutic use)
  • Ammonia (blood)
  • Carbamoyl-Phosphate Synthase (Ammonia) (deficiency)
  • Coma (blood, etiology, therapy)
  • Dialysis Solutions (therapeutic use)
  • Fatal Outcome
  • Female
  • Hemodiafiltration (methods)
  • Humans
  • Infant, Newborn
  • Phosphates (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: